Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Currently available GLP-1 receptor agonists have variable effects on fasting and postprandial blood glucose levels: short-acting GLP-1 receptor agonists have a greater effect on postprandial glucose and long-acting agents have a greater relative effect on fasting glucose ( Table 5 )
doi: 10.1053/j.gastro.2012.06.031 157 GhaniRMullishBHRobertsLADaviesFJMarchesiJR
This medication is also used to help lower the risk of various cardiovascular diseases and worsening kidney disease (in patients with chronic kidney disease and type 2 diabetes)
Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]
Retrieved from Tabrizi, R., Saneei, P., Lankarani, K
